ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

TLSI TriSalus Life Sciences Inc

9.66
0.00 (0.00%)
Pre Mercado
Última actualización: 06:00:05
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
TriSalus Life Sciences Inc TLSI NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 9.66 06:00:05
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
9.66
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
07/5/202406:00BWTriSalus Life Sciences Appoints Liselotte Hyveled to its..
06/5/202415:58BWTriSalus Life Sciences to Host First Quarter 2024 Financial..
30/4/202415:35BWTriSalus Life Sciences Secures up to $50 million of Debt..
01/4/202407:00BWTriSalus Reports Q4 and Full Year 2023 Financial Results and..
26/3/202407:00BWTriSalus Life Sciences Technology Featured in Two..
21/3/202407:00BWTriSalus Life Sciences Announces Oral Presentations at the..
11/3/202416:15BWTriSalus Life Sciences Announces Q4 Conference Call and..
07/3/202406:00BWTriSalus Life Sciences Receives Approval from the World..
29/2/202406:00BWTriSalus Life Sciences Announces Real-World Data..
14/2/202417:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202417:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202417:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202417:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202417:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202416:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202416:23EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
25/1/202416:21EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
25/1/202416:19EDGAR2Form 8-K - Current report
05/1/202415:28EDGAR2Form 8-K - Current report
26/12/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
26/12/202316:28EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
26/12/202316:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/11/202307:00BWTriSalus Reports Third Quarter 2023 Financial Results and..
07/11/202315:05BWTriSalus Life Sciences to Host Third Quarter 2023 Financial..
04/11/202313:25BWLate-Breaking Phase 1 Liver Metastasis Data from TriSalus..
03/11/202311:00BWTriSalus Life Sciences Presents Data for SD-101 Delivered by..
25/10/202308:05BWTriSalus Life Sciences Announces Late Breaker and Additional..
18/10/202320:58EDGAR2Form S-1/A - General form for registration of securities..
16/10/202316:23EDGAR2Form S-8 - Securities to be offered to employees in employee..
03/10/202305:01EDGAR2Form 8-K - Current report
06/9/202306:00BWTriSalus Life Sciences Appoints Jodi Devlin as President of..
01/9/202315:47EDGAR2Form S-1/A - General form for registration of securities..
01/9/202315:01EDGAR2Form 8-K - Current report
31/8/202320:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202320:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/8/202316:22EDGAR2Form S-1 - General form for registration of securities under..
29/8/202307:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
21/8/202315:33EDGAR2Form SC 13D - General statement of acquisition of beneficial..
16/8/202315:37EDGAR2Form 8-K - Current report

Su Consulta Reciente

Delayed Upgrade Clock